Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 283 contracts
Sources: Securities Purchase Agreement (AppTech Payments Corp.), Securities Purchase Agreement (Propanc Biopharma, Inc.), Securities Purchase Agreement (Kisses From Italy Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 221 contracts
Sources: Securities Purchase Agreement (Propanc Biopharma, Inc.), Securities Purchase Agreement (Propanc Biopharma, Inc.), Securities Purchase Agreement (Propanc Biopharma, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 211 contracts
Sources: Securities Purchase Agreement (Arch Therapeutics, Inc.), Securities Purchase Agreement (Arch Therapeutics, Inc.), Securities Purchase Agreement (NextTrip, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission”.
Appears in 53 contracts
Sources: Securities Purchase Agreement (Grom Social Enterprises, Inc.), Securities Purchase Agreement (Digital Development Partners, Inc.), Securities Purchase Agreement (Renavotio, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 12 contracts
Sources: Securities Purchase Agreement (Tribal Rides International Corp.), Securities Purchase Agreement (SusGlobal Energy Corp.), Securities Purchase Agreement (SusGlobal Energy Corp.)
Bad Actor. No officer or director of the Company Borrower would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 4 contracts
Sources: Securities Purchase Agreement (SMX (Security Matters) Public LTD Co), Securities Purchase Agreement (SMX (Security Matters) Public LTD Co), Securities Purchase Agreement (Bruush Oral Care Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities 1933 Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 3 contracts
Sources: Securities Purchase Agreement (C-Bond Systems, Inc), Securities Purchase Agreement (Clubhouse Media Group, Inc.), Securities Purchase Agreement (Clubhouse Media Group, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.. PW
Appears in 2 contracts
Sources: Securities Purchase Agreement (Pharmagreen Biotech Inc.), Securities Purchase Agreement (Pharmagreen Biotech Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) 506 of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Friendable, Inc.), Securities Purchase Agreement (Friendable, Inc.)
Bad Actor. No To the Company’s knowledge, no officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Guided Therapeutics Inc), Securities Purchase Agreement (Guided Therapeutics Inc)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities 1933 Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 2 contracts
Sources: Securities Purchase Agreement (C-Bond Systems, Inc), Securities Purchase Agreement (C-Bond Systems, Inc)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 2013, Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Smart Decision, Inc.), Securities Purchase Agreement (Smart Decision, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Sources: Securities Purchase Agreement (Endonovo Therapeutics, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities 1934 Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 1 contract
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d506( d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Sources: Securities Purchase Agreement (Guided Therapeutics Inc)
Bad Actor. No officer or director of the Company would be is disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 1 contract
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, January 5 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Sources: Securities Purchase Agreement (Airborne Wireless Network)
Bad Actor. No officer or director of the Company Buyer would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 1 contract
Sources: Securities Purchase Agreement (Inception Mining Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ’ as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Sources: Securities Purchase Agreement (Alkame Holdings, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September December 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Sources: Securities Purchase Agreement (Endonovo Therapeutics, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, March 30 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Sources: Securities Purchase Agreement (Airborne Wireless Network)